Is Bariatric Surgery Effective in Reducing Comorbidities and Drug Costs? A Systematic Review and Meta-Analysis
- 26 June 2015
- journal article
- research article
- Published by Springer Science and Business Media LLC in Obesity Surgery
- Vol. 25 (9), 1741-1749
- https://doi.org/10.1007/s11695-015-1777-5
Abstract
The aim of this study was to assess drug use and costs before and after bariatric surgery (BS). A systematic review of the literature was carried out using the MeSH terms obesity, bariatric surgery, and drug costs for searches of 10 electronic databases up to July 2014. Data were extracted from the 11 studies (37,720 patients) that fulfilled the inclusion criteria. Where applicable, data were pooled by meta-analysis. The average number of drugs per patient decreased from 3.9 ± 1.86 before surgery to 1.75 ± 1.85 after surgery. Mean reduction in total cost of drugs was 49.8 % over a follow-up duration of 6–72 months. BS is effective for the improvement or resolution of comorbidities and significantly reduces drug use and costs.This publication has 33 references indexed in Scilit:
- Insulin Sensitivity and Secretion Changes After Gastric Bypass in Normotolerant and Diabetic Obese SubjectsAnnals of Surgery, 2013
- Impact of Bariatric Surgery on Health Care Utilization and Costs Among Patients With DiabetesMedical Care, 2012
- Bariatric Surgery: A Systematic Review of the Clinical and Economic EvidenceJournal of General Internal Medicine, 2011
- Medication use after bariatric surgery in a managed care cohortSurgery for Obesity and Related Diseases, 2008
- Studies of Swedish adjustable gastric band and Lap-Band: systematic review and meta-analysisSurgery for Obesity and Related Diseases, 2008
- Predictive Factors of Outcome After Gastric BandingAnnals of Surgery, 2007
- The effect of laparoscopic gastric bypass surgery on dyslipidemia in severely obese patientsSurgery for Obesity and Related Diseases, 2005
- Laparoscopic gastric bypass results in decreased prescription medication costs within 6 monthsJournal of Gastrointestinal Surgery, 2004
- Quantifying heterogeneity in a meta-analysisStatistics in Medicine, 2002
- Long-term effects of weight loss on pharmaceutical costs in obese subjects. A report from the SOS intervention studyInternational Journal of Obesity, 2002